Corporate Europe Observatory

Exposing the power of corporate lobbying in the EU

Pages

 
 
 
 
 
 
-- placeholder --
 
 
 

The corporate lobby tour

The official EU assessment of glyphosate was based on unpublished studies owned by industry. Seven months later, the pesticide industry still fights disclosure and, so far, successfully. We obtained a copy of their arguments.

While CEO is not taking a position on the UK referendum, many of our publications are relevant to those who will have a vote, or those who are following the debate.

The European Commission proposal on scientific criteria defining endocrine disruptors (EDCs) is the latest dangerous outgrowth of a highly toxic debate. The chemical lobby, supported by certain Commission factions (notably DG SANTE and the Secretary-General) and some member states (UK and Germany), has put significant obstacles in the way of effective public health and environment regulation.

The financial sector has used the threat of Brexit via the UK referendum on EU membership to promote its deregulatory agenda since 2013, according to a new study (1) by Corporate Europe Observatory.